Two RNA-editing therapies for genetic diseases have recently gained approval for clinical trials, raising hopes for safer treatments. Two RNA-editing therapies for genetic diseases have recently gained approval for clinical trials, raising hopes for safer treatments.
A different form of a gene called CHD1L found in people with African ancestry has been linked to lower HIV levels in people infected with the virus, and the discovery could open the door to improved treatments